Literature DB >> 7868943

Characterization of three cloned cell lines from a N-nitrosobis(2-hydroxypropyl)amine-induced transplantable hamster pancreatic ductal adenocarcinoma.

T Mori1, M Tsutsumi, O Noguchi, K Horiguchi, K Hohnoki, S Okita, F Suzuki, Y Konishi.   

Abstract

To investigate characteristics of pancreatic carcinoma growth behavior, the cloned cell lines, HPD1NR, HPD2NR, and HPD3NR, were established from a transplantable hamster ductal adenocarcinoma induced by N-nitrosobis(2-hydroxypropyl)amine (BHP). All three clones showed similar epithelial cell morphology and grew as sheets in culture with no differences in doubling times, ranging from 23-28 h. Mutation in the c-Ki-ras exon 1 was detected in common. The modal chromosome numbers were also found to be similar at 60, 62, and 60-62 in the less than tetraploid cells in the three clones. In contrast, a clear difference in frequencies of tetraploid or polyploid cells at 24.7, 22.5, and 75.5% in HPD1NR, HPD2NR, and HPD3NR, respectively, was evident. Tumorigenic potency evaluated by transplanting individual clones revealed HPD3NR to display pronouncedly less growth in syngeneic hamsters. The results suggest that increase in frequency of tetraploid or polyploid cells might be associated with a decreased in vivo growth potential of hamster pancreatic ductal adenocarcinomas, and suggest that these clones might become a valuable tool for understanding in vivo growth mechanisms of cancer cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7868943     DOI: 10.1007/bf02944328

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  25 in total

1.  Establishment and characterization of a carcinoembryonic antigen producing cell line derived from human pancreatic exocrine cancer.

Authors:  N Yamaguchi; G Uozumi; H Ikeuchi; H Morioka; M Machino; K Kawai
Journal:  Gastroenterol Jpn       Date:  1983-12

2.  Partial characterisation of an oncofetal pancreatic antigen. Its role in the differential diagnosis and therapy of patients with pancreatic cancer.

Authors:  M L Knapp
Journal:  Ann Clin Biochem       Date:  1981-05       Impact factor: 2.057

3.  KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas.

Authors:  V T Smit; A J Boot; A M Smits; G J Fleuren; C J Cornelisse; J L Bos
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

4.  Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12.

Authors:  H Fujii; H Egami; W Chaney; P Pour; J Pelling
Journal:  Mol Carcinog       Date:  1990       Impact factor: 4.784

5.  Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma.

Authors:  H P Elsässer; U Lehr; B Agricola; H F Kern
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1992

6.  Establishment and characterization of a cultured cell line derived from nitrosamine-induced pancreatic ductal adenocarcinoma in Syrian golden hamsters.

Authors:  S Saito; N Nishimura; Y Kubota; K Yamazaki; T Shibuya; H Sasaki
Journal:  Gastroenterol Jpn       Date:  1988-04

7.  Cancer of the pancreas induced in the Syrian golden hamster.

Authors:  P Pour; F W Krüger; J Althoff; A Cardesa; U Mohr
Journal:  Am J Pathol       Date:  1974-08       Impact factor: 4.307

8.  Cell differentiation during pancreatic carcinogenesis.

Authors:  P M Pour
Journal:  Scand J Gastroenterol Suppl       Date:  1988

9.  Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine.

Authors:  M Tsutsumi; Y Murakami; S Kondoh; T Tsujiuchi; K Hohnoki; K Horiguchi; O Noguchi; E Kobayashi; S Okita; T Sekiya
Journal:  Jpn J Cancer Res       Date:  1993-09

10.  Effects of 3-aminobenzamide on induction of multiorgan carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in hamsters.

Authors:  T Tsujiuchi; M Tsutsumi; A Denda; T Amanuma; S Kondoh; K Kamino; Y Konishi
Journal:  Jpn J Cancer Res       Date:  1991-07
View more
  6 in total

1.  K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.

Authors:  N Erill; M Cuatrecasas; F J Sancho; A Farré; P M Pour; F Lluís; G Capellá
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

2.  Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.

Authors:  Kohei Kato; Kyohei Yoshikawa; Eriko Tanabe; Misaho Kitayoshi; Rie Fukui; Nobuyuki Fukushima; Toshifumi Tsujiuchi
Journal:  Tumour Biol       Date:  2012-06-08

3.  Infrequent mutation of lysophosphatidic Acid receptor-1 gene in hamster pancreatic duct adenocarcinomas and established cell lines.

Authors:  Toshifumi Tsujiuchi; Mami Furukawa; Yumi Obo; Ayako Yamasaki; Mayuko Hotta; Chie Kusunoki; Naoko Suyama; Toshio Mori; Kanya Honoki; Nobuyuki Fukushima
Journal:  J Toxicol Pathol       Date:  2009-04-06       Impact factor: 1.628

4.  Overexpression of midkine in pancreatic duct adenocarcinomas induced by N-Nitrosobis(2-oxopropyl)amine in hamsters and their cell lines.

Authors:  M Tsutsumi; K Kadomatsu; T Tsujiuchi; H Sakitani; S Ikematsu; T Kubozoe; M Yoshimoto; T Muramatsu; S Sakuma; Y Konishi
Journal:  Jpn J Cancer Res       Date:  2000-10

5.  Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2.

Authors:  Akihisa Kato; Aya Naiki-Ito; Takahiro Nakazawa; Kazuki Hayashi; Itaru Naitoh; Katsuyuki Miyabe; Shuya Shimizu; Hiromu Kondo; Yuji Nishi; Michihiro Yoshida; Shuichiro Umemura; Yasuki Hori; Toshio Mori; Masahiro Tsutsumi; Toshiya Kuno; Shugo Suzuki; Hiroyuki Kato; Hirotaka Ohara; Takashi Joh; Satoru Takahashi
Journal:  Oncotarget       Date:  2015-12-15

6.  Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia.

Authors:  Sujit Suklabaidya; Biswajit Das; Syed Azmal Ali; Sumeet Jain; Sharada Swaminathan; Ashok K Mohanty; Susen K Panda; Pujarini Dash; Subhankar Chakraborty; Surinder K Batra; Shantibhusan Senapati
Journal:  Oncotarget       Date:  2016-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.